Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study
We identified several amino acid substitutions outside the established DRMs that are strongly associated with predicted dolutegravir resistance. Dolutegravir resistance evolution is complex and likely involves mutations not currently classified as DRMs.
Institutions
- University of Bern (CH)
- Centre for Infectious Disease Research in Zambia (ZM)
- AIDS Healthcare Foundation (US)
- Mbarara University of Science and Technology (UG)
- University of Cape Town (ZA)
- University of Zurich (CH)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- Masaka Hospital (UG)
- Education and Research Network (IN)
- Nazi Boni University (BF)
- University of Alabama at Birmingham (US)
- University of Bristol (GB)
- Lighthouse Trust (MW)
- Public Health Department (IN)
- Biomedical Research and Training Institute (ZW)
- University Hospital of Zurich (CH)
- Centre Hospitalier et Universitaire de Brazzaville (CG)
- Infectious Diseases Institute (UG)
- CHU Dijon Bourgogne (FR)
- Goodlife (Netherlands) (NL)
- Société de Développement des Forêts (CI)
- Institute of Social and Preventive Medicine (CH)
- Programme PAC-CI (CI)
- West African Health Organisation (BF)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Makerere University (UG)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1093/jac/dkag088
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00